Search term:
2009 / 06 / 08
PHARMAC documents that matched your search:
1. Guidelines for Pulmonary Arterial Hypertension (PAH) Therapy Special Authority applications
(5 pages, 148 KB)
2009/06/08
ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY These guidelines are intended to assist relevant practitioners in gauging which patients are likely to be approved for pulmonary arterial hypertension treatments. In view of the complexity of pulmonary arterial hypertension…
2. Adults Initial PAH application form
(9 pages, 166 KB)
2009/06/08
Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) Please send applications to: PAH Panel Coordinator PHARMAC P O Box 10-254 WELLINGTON Phone: 04 9167 512 Facsimile: 04 460 4858 Email: PAH@pharmac.govt.nz…
3. Adults Renewal PAH application form
(4 pages, 159 KB)
2009/06/08
Renewal Application / Request for Change of Therapy for Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) Use this form for renewal applications and applications for therapy changes. Initial approval is valid for a period of…
4. Children Initial PAH application form
(5 pages, 122 KB)
2009/06/08
Initial Application for Funding of Pulmonary Arterial Hypertension Treatment Application for children less than 10 years for PDE-5 inhibitor (sildenafil) treatment This form is applicable for younger patients requiring PDE-5 inhibitor (sildenafil) monotherapy only. If other treatments are required use…
5. Children Renewal PAH application form
(5 pages, 123 KB)
2009/06/08
Renewal Application for Funding of Pulmonary Arterial Hypertension Treatment Application for children less than 10 years for PDE-5 inhibitor (sildenafil) treatment This form is applicable for younger patients requiring PDE-5 inhibitor (sildenafil) monotherapy only. If other treatments are required use…
Discontinuation of Nuvelle
(1 page, 146 KB)
2009/06/08
08 June 2009 Discontinuation of Nuvelle Bayer New Zealand Ltd has discontinued Nuvelle and stock in New Zealand has been exhausted. PHARMAC apologises for the delay in announcing the alternatives for this product as clinical advice was required from the…
Funding for pulmonary arterial hypertension treatments approved
(2 pages, 41 KB)
2009/06/08
8 June 2009 Funding for pulmonary arterial hypertension treatments approved PHARMAC is pleased to announce that the approval of a proposal relating to the funding of treatments for pulmonary arterial hypertension. This was the subject of a consultation letter dated…
Information from PHARMAC's 2006 High Cost Medicines Review Released As Contribution To Government's Work On 'High-Cost Highly Specialised' Medicines
(3 pages, 22 KB)
2009/06/08
INFORMATION FROM PHARMAC’s 2006 HIGH COST MEDICINES REVIEW RELEASED AS CONTRIBUTION TO GOVERNMENT’S WORK ON `HIGH-COST HIGHLY SPECIALISED’ MEDICINES Summary The Government has recently established an independent review panel to investigate improving access to ‘high-cost highly specialised’ medicines. PHARMAC undertook…
Notification of approval of Diabetes Management Products and Mesalazine proposals
(9 pages, 237 KB)
2009/06/08
8 June 2009 Approval of Multiple Mesalazine proposals Diabetes Management Products and PHARMAC is pleased to announce the approval of five agreements in relation to funding of blood glucose test strips, blood glucose diagnostic test meters, blood ketone test strips,…
Notification of approval of pioglitazone sole supply arrangement and widening of access
(4 pages, 37 KB)
2009/06/08
8 June 2009 Pioglitazone sole supply arrangement and widening of access PHARMAC is pleased to announce the widening of access to pioglitazone via a sole supply agreement with Douglas Pharmaceuticals. Pioglitazone belongs to a group of medicines called thiazolidinediones and…
Search tips
Search or Browse
To search for a document enter a search term into the search form and activate the Search button.
Documents may be browsed by date, eg; Today, February, 2012.
Past years can be browsed too...
2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2012
Search terms
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReview, archive, BoardPaper, BusinessPlan, CAC, CACminutes, CCNotifications, ClinNewsletter, consultation, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, LetterOfExpectations, media, notification, OIA, OutputAgreement, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, ScheduleDispatch, SchedulePublications, SectionH, SOI, tender, update, vacancy, WhatsNew.
Documents with related dates can be browsed through the date component links below the document title.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
